Oasmia Pharmaceutical AB operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Oasmia Pharmaceutical AB with three other
pharmaceutical manufacturers in Europe:
Celon Pharma SA
sales of 1.54 million Polish New Zlotys [US$410,699.34 ]
of the United Kingdom
(£361,000.00 [US$468,224.22 ]
based in Switzerland
(399,963.00 Swiss Francs [US$409,798.09 ]
of which 100%
was Pharmaceuticals Manufacture).